Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1802 (LINC01802) is a non-protein coding RNA gene in humans, annotated as a member of the lincRNA subclass of long non-coding RNAs[1][3]. LincRNAs are autonomously transcribed RNAs longer than 200 nucleotides that do not overlap protein-coding loci. They play diverse biological regulatory functions, including transcriptional regulation, chromatin organization, and modulation of RNA stability and processing, and serve as molecular scaffolds for protein complexes[5]. LINC01802 itself is referenced in genomic databases with confirmed annotation, but as of this date it is not associated with specific biological functions, disease connections, or therapeutic targeting. There is no evidence of misspelling or incorrect classification. Its role is currently uncharacterized among lincRNAs, and no alternative names or synonyms exist beyond its formal designation.
No drugs or molecules are documented to act on LINC01802
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1802 (LINC01802).